Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease

by S. Matthijs Boekholdt, John F. Thompson
Published 2003-06-01

Protocol dependence of sequencing-based gene expression measurements.

by Tal Raz, Philipp Kapranov, Doron Lipson, Stan Letovsky, Patrice M Milos, John F Thompson
Published 2011-05-01

High-density genotyping and functional SNP localization in the CETP genes⃞

by John F. Thompson, Linda S. Wood, Eve H. Pickering, Bryan DeChairo, Craig L. Hyde
Published 2007-02-01

Expression of CETP and of splice variants induces the same level of ER stress despite secretion efficiency differences

by Maruja E. Lira, A. Katrina Loomis, Sara A. Paciga, David B. Lloyd, John F. Thompson
Published 2008-09-01

Regulation of apoAI processing by procollagen C-proteinase enhancer-2 and bone morphogenetic protein-1

by Jian Zhu, Joseph Gardner, Clive R. Pullinger, John P. Kane, John F. Thompson, Omar L. Francone
Published 2009-07-01

Surgical excision margins for primary cutaneous melanoma

by Michael J Sladden, Charles Balch, David A Barzilai, Daniel Berg, Anatoli Freiman, Teenah Handiside, Sally Hollis, Marko B Lens, John F Thompson
Published 2011-01-01

p16INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors

by Stuart J. Gallagher, John F. Thompson, James Indsto, Lyndee L. Scurr, Margaret Lett, Bo-Fu Gao, Ruth Dunleavey, Graham J. Mann, Richard F. Kefford, Helen Rizos
Published 2008-11-01

GPs’ involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study

by Andrea L Smith, Caroline G Watts, Samuel Robinson, Helen Schmid, Chiao-Han Chang, John F Thompson, Frances Rapport, Anne E Cust, Australian Melanoma Centre of Research Excellence Study Group
Published 2020-04-01

Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients

by Tuba N. Gide, Ines P. Silva, Camelia Quek, Tasnia Ahmed, Alexander M. Menzies, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, Marcel Batten, Georgina V. Long, Richard A. Scolyer, James S. Wilmott
Published 2020-01-01

Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15.

by Huei-Mei Chen, Rachel Resendes, Azita Ghodssi, Danielle Sookiasian, Michael Tian, Serena Dollive, Laura Adamson-Small, Nancy Avila, Cagdas Tazearslan, John F Thompson, Jeff L Ellsworth, Omar Francone, Albert Seymour, Jason B Wright
Published 2020-01-01

Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets

by Tuba N. Gide, Inês Pires da Silva, Camelia Quek, Peter M. Ferguson, Marcel Batten, Ping Shang, Tasnia Ahmed, Alexander M. Menzies, Matteo S. Carlino, Robyn P. M. Saw, John F. Thompson, Richard A. Scolyer, Georgina V. Long, James S. Wilmott
Published 2021-06-01

Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma

by Elena Shklovskaya, Jenny H Lee, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Peter Ferguson, Robyn PM Saw, John F Thompson, Brindha Shivalingam, Matteo S Carlino, Richard A Scolyer, Alexander M Menzies, Georgina V Long, Richard F Kefford, Helen Rizos
Published 2020-11-01

Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value

by Raymond Barnhill, Pieter‐Jan vanDam, Peter Vermeulen, Gabriel Champenois, André Nicolas, Robert V Rawson, James S Wilmott, John F Thompson, Georgina V Long, Nathalie Cassoux, Sergio Roman‐Roman, Klaus J Busam, Richard A Scolyer, Alexander J Lazar, Claire Lugassy
Published 2020-07-01

Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods s...

by Michael Henderson, Frances Rapport, Rachael L Morton, John F Thompson, Andrea L Smith, Anne E Cust, Graham J Mann, Caroline G Watts, David E Gyorki, Angela M Hong, John W Kelly, Victoria J Mar, Robyn PM Saw, Richard A Scolyer, Andrew J Spillane
Published 2020-02-01

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition

by Jenny H. Lee, Elena Shklovskaya, Su Yin Lim, Matteo S. Carlino, Alexander M. Menzies, Ashleigh Stewart, Bernadette Pedersen, Malama Irvine, Sara Alavi, Jean Y. H. Yang, Dario Strbenac, Robyn P. M. Saw, John F. Thompson, James S. Wilmott, Richard A. Scolyer, Georgina V. Long, Richard F. Kefford, Helen Rizos
Published 2020-04-01

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

by Mitchell S. Stark, Kerenaftali Klein, Benjamin Weide, Lauren E. Haydu, Annette Pflugfelder, Yue Hang Tang, Jane M. Palmer, David C. Whiteman, Richard A. Scolyer, Graham J. Mann, John F. Thompson, Georgina V. Long, Andrew P. Barbour, H. Peter Soyer, Claus Garbe, Adrian Herington, Pamela M. Pollock, Nicholas K. Hayward
Published 2015-07-01

Epigenetic profiling for the molecular classification of metastatic brain tumors

by Javier I. J. Orozco, Theo A. Knijnenburg, Ayla O. Manughian-Peter, Matthew P. Salomon, Garni Barkhoudarian, John R. Jalas, James S. Wilmott, Parvinder Hothi, Xiaowen Wang, Yuki Takasumi, Michael E. Buckland, John F. Thompson, Georgina V. Long, Charles S. Cobbs, Ilya Shmulevich, Daniel F. Kelly, Richard A. Scolyer, Dave S. B. Hoon, Diego M. Marzese
Published 2018-11-01

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

by Serigne N. Lo, Angela M. Hong, Lauren E. Haydu, Tasnia Ahmed, Elizabeth J. Paton, Victoria Steel, George Hruby, Anh Tran, Rachael L. Morton, Anna K. Nowak, Janette L. Vardy, Katharine J. Drummond, Haryana M. Dhillon, Catherine Mandel, Richard A. Scolyer, Mark R. Middleton, Bryan H. Burmeister, John F. Thompson, Gerald B. Fogarty
Published 2019-08-01

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker

by Grant M. Fischer, Fernando C. L. Carapeto, Aron Y. Joon, Lauren E. Haydu, Huiqin Chen, Fuchenchu Wang, John S. Van Arnam, Jennifer L. McQuade, Khalida Wani, John M. Kirkwood, John F. Thompson, Michael T. Tetzlaff, Alexander J. Lazar, Hussein A. Tawbi, Jeffrey E. Gershenwald, Richard A. Scolyer, Georgina V. Long, Michael A. Davies
Published 2020-11-01

LNK suppresses interferon signaling in melanoma

by Ling-Wen Ding, Qiao-Yang Sun, Jarem J. Edwards, Lucia Torres Fernández, Xue-Bin Ran, Si-Qin Zhou, Richard A. Scolyer, James S. Wilmott, John F. Thompson, Ngan Doan, Jonathan W. Said, Nachiyappan Venkatachalam, Jin-Fen Xiao, Xin-Yi Loh, Maren Pein, Liang Xu, David W. Mullins, Henry Yang, De-Chen Lin, H. Phillip Koeffler
Published 2019-05-01